How to Request and Match a Peptide COA to a Product Batch
A practical guide to requesting a peptide COA, matching product strength and batch references, and interpreting documentation for individual peptides and blends.
Why an exact product and batch match matters
A Certificate of Analysis describes the sample identified on that document. Before treating a report as relevant, compare the product name, stated strength, batch or lot reference, document number and issue date with the label on the supplied material. A COA for another strength or an older batch should not be transferred to current stock without a documented connection.
This distinction matters even when two catalogue entries share a familiar peptide name. GHK-Cu 50mg and GHK-Cu 100mg are separate strengths; GLP-3 or Retatrutide 10mg and 30mg are separate catalogue records. Each requires documentation that identifies the corresponding material and batch.
Understand the three documentation statuses
Published batch COA means a document is publicly linked to the exact product strength. It must still be matched to the batch reference on the supplied label. Being tested means new batch documentation is undergoing testing and is not yet publicly linked; use Request COA rather than assuming a result. Archived or not current means an older record is retained for transparency but is not evidence for current stock.
An archived report can show how a previous sample was described and tested, but it cannot establish the identity, purity, assay, sterility, endotoxin status or release status of a later batch. The current JGPep+ COA library separates archived records from current public documents.
What to include when requesting a COA
Send the exact product name, strength, batch or lot reference shown on the label, order number where available and a clear photograph of the label if the reference is difficult to read. For example, request documentation for GHK-Cu 50mg rather than asking generally for a GHK-Cu certificate.
For an order that has not yet arrived, identify the exact catalogue product and strength and ask whether documentation for the batch intended for supply is currently available. A response that provides a report for a different strength or batch should be clarified before the document is relied upon.
Individual peptides: GHK-Cu, BPC-157 and GLP-3
Reference databases and primary research can help define literature context, but they do not verify a commercial batch. PubChem records GHK-Cu as a copper tripeptide and records a defined sequence and chemical identifiers for BPC-157. Those reference records help researchers check naming conventions; they do not prove that a JGPep+ vial has a particular identity, amount or purity.
The same separation applies to GLP-3 or Retatrutide. Published clinical research identifies Retatrutide as a triple-receptor agonist studied in defined investigational settings, but a journal article is not a batch certificate. Product documentation must still identify the exact catalogue strength and supplied lot.
Peptide blends: GLOW and KLOW need component-level clarity
A blend name is not a complete analytical description. GLOW and KLOW are multi-component catalogue products, so a useful document should identify the blend, nominal total amount, submitted component description, relevant component allocation and batch reference. A report for one ingredient alone does not establish the composition or uniformity of the complete blend.
Likewise, a COA for standalone GHK-Cu or BPC-157 should not be presented as the COA for GLOW or KLOW. Each blend requires product-specific documentation. Where a supplier-designated component name is used, the document should define the material clearly enough for the laboratory to understand what was submitted for analysis.
Read each result within the method's limits
ICH Q2(R2) explains that analytical procedures should be fit for their intended purpose and considers characteristics such as specificity, accuracy and precision. When reviewing a COA, connect each reported result to the stated method, sample, units, acceptance criteria and limitations.
HPLC peak-area purity, molecular-mass information, quantitative assay and endotoxin screening answer different questions. One result should not be expanded into an unsupported claim about every quality attribute. Data-integrity guidance also reinforces the importance of complete, attributable and reviewable records rather than isolated screenshots or copied percentages.
A practical pre-order and receipt checklist
Before ordering, open the product page, confirm the exact strength and review its documentation status. If the page says Request COA, ask for the current batch document before relying on any analytical claim. If a document is published, note its batch reference and do not assume that it will match stock until the supplied label is checked.
On receipt, compare the label with the report, retain the document with the batch record and record who performed the review. Escalate missing identifiers, mismatched strengths, unclear component descriptions or inconsistent batch references. JGPep+ materials and this guide are strictly for lawful laboratory research and analytical use, not for human or veterinary use.
Research use only. Not for human or veterinary use.